MALVERN, PA — The Drug Channels Institute, an HMP Global Company, will host a high-profile gathering of drug channel executives at the Drug Channels Leadership Forum in March 2025. The event aims to provide a platform for key stakeholders in the pharmaceutical supply chain to discuss pressing issues surrounding prescription drug supply and access.
Scheduled for March 17-19, 2025, at the Turnberry Resort and Spa in Miami, the forum will feature candid discussions on the future of drug channels. Moderated by Adam J. Fein, Ph.D., President of Drug Channels Institute, the program will include one-on-one conversations with top industry leaders and policymakers.
“We are bringing together top executives from Eli Lilly and Company, Cencora, Optum Rx, and Walgreens,” Fein said. “They lead some of the most significant businesses operating throughout U.S. drug channels. Our one-on-one conversations will help illuminate crucial issues and key strategic concerns affecting the prescription drug market and the entire U.S. healthcare system.”
Confirmed executives for individual fireside chats with Fein include:
- Steven H. Collis, Chairman, President, and CEO, Cencora, Inc.
- Patrick Conway, MD, MSc, CEO, Optum Rx
- Frank Cunningham, Group Vice President, Global Value and Access & Lilly Direct, Eli Lilly and Company
- Tim Wentworth, CEO, Walgreens Boots Alliance, Inc.
The event will also feature four panel discussions on various critical topics. Details about the participants in these panels will be announced this fall.
The forum’s salon-style format is designed to foster open dialogue, with lively discussions and debates on the complexities of the drug channel landscape. Topics will include industry disruptors, success drivers, and the rapidly evolving pharmaceutical ecosystem.
The Drug Channels Leadership Forum targets executives from pharmaceutical manufacturers, pharmacy benefit managers (PBMs), health plans, insurers, pharmaceutical wholesalers, hospitals, health systems, physician practices, and government entities. This diverse audience will have the opportunity to engage with industry leaders, exchange ideas, and gain insights into the strategic challenges and opportunities shaping the future of drug channels in the United States.
This event promises to be a significant gathering for anyone involved in the pharmaceutical supply chain, offering invaluable perspectives and fostering collaboration across the industry.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.